Marijuana Internacional

"Patients diagnosed with cholangiocarcinoma, who integrate cannabis into their palliative medical treatment experience prolonged survival compared to those who do not, according to the findings of a retrospective cohort study published in the scientific journal F1000 Research.
.
For those receiving
standard care only, the median survival time after registration at a palliative clinic was 0.83 months. For those receiving cannabis, median survival time was 5.66 months.
.
“Medical cannabis increased overall survival rates among CCA patients,” the study’s authors concluded. “Our findings
support the integration of medicinal cannabis into palliative care.”
.
 
Werbung:
"Cannabis use is associated with sustained reductions in analgesia* and improvements in glycemic* control in patients suffering from diabetic neuropathy*, according to longitudinal data published in the journal Biomedicines.
.
Israeli researchers assessed the adjunctive use of inhaled cannabis in a cohort of 50
patients suffering from treatment-resistant diabetic neuropathy. Study participants inhaled standardized, medical-grade cannabis flower (20 percent THC | 1 percent CBD) for five years.
.

Patients reported significant decreases in their pain scores, as well reductions in their use of opioids and other prescription analgesics*, over the span of the study. Specifically, participants decreased their morphine-equivalent doses by more than 90 percent, their gabapentin* doses by 97 percent, duloxetine* by 93 percent, and pregabalin* by 79 percent without developing rebound pain. Patientspain severity decreased from a mean of nine to two on a numerical rating scale."
.
* Helping the least-educated wherever you can.
.
Leftists don't see any harm in blowing one's mind on drugs. Maybe they have a valid point about themselves.
1762032171967.webp

1762032198009.gif

1762032248586.webp


1762032279588.webp
 
"Older adults with a history of cannabis use exhibit superior cognitive performance and slower age-related declines in executive function, according to data published in the journal Age and Ageing.
.
Israeli researchers assessed cognitive performance in a cohort of
more than 67,000 adults (mean age: 67 years old).
.
Compared to
non-users, participants with a history of cannabis use “performed better across all cognitive domains: attention, executive function, processing speed, visual and working memory. … Additionally, past use was associated with a slower decline in executive function.”
.
 
"Cannabis use is associated with a reduced risk of oral cancer, according to the results of a systematic review and meta-analysis published in the Journal of Ethnicity in Substance Abuse.
.
An
international team of investigators from Jordan, Iraq, and Uzbekistan reviewed data from six case-control studies involving over 15,000 subjects.
.
While
cannabinoids have demonstrated well-established anti-cancer activities in preclinical models, their efficacy as an anti-cancer agent has rarely been assessed in clinical trials."
.
 
"Cannabis use is associated with a reduced risk of oral cancer, according to the results of a systematic review and meta-analysis published in the Journal of Ethnicity in Substance Abuse.
.
An
international team of investigators from Jordan, Iraq, and Uzbekistan reviewed data from six case-control studies involving over 15,000 subjects.
.
While
cannabinoids have demonstrated well-established anti-cancer activities in preclinical models, their efficacy as an anti-cancer agent has rarely been assessed in clinical trials."
.
The damage that marijuana does to the brain is likely permanent.
 
"Adults with a history of recent cannabis use are less likely to suffer from metabolic syndrome (aka MetS, a cluster of biochemical and physiological markers associated with the development of cardiovascular disease and type 2 diabetes) as compared to similarly matched controls, according to data published in the journal Schizophrenia Research."
.
 
"Adults with a history of recent cannabis use are less likely to suffer from metabolic syndrome (aka MetS, a cluster of biochemical and physiological markers associated with the development of cardiovascular disease and type 2 diabetes) as compared to similarly matched controls, according to data published in the journal Schizophrenia Research."
.
The harm caused by marijuana use is likely far greater and more permanent than the supposed benefits.
 
"The daily use of CBD reduces dementia symptoms, according to placebo-controlled clinical trial data published in the Journal of Psychopharmacology.
.
Brazilian researchers assessed the efficacy of
CBD versus a placebo in 30 older patients with vascular dementia. Study participants consumed either 300mg doses of CBD or the placebo for four weeks.
.

CBD administration significantly reduced patientsbehavioral and psychiatric symptoms compared to placebo. CBD dosing did not adversely impact patients’ cognitive functioning, nor was it associated with any other significant side effects."
.
 
"The daily use of CBD reduces dementia symptoms, according to placebo-controlled clinical trial data published in the Journal of Psychopharmacology.
.
Brazilian researchers assessed the efficacy of
CBD versus a placebo in 30 older patients with vascular dementia. Study participants consumed either 300mg doses of CBD or the placebo for four weeks.
.

CBD administration significantly reduced patientsbehavioral and psychiatric symptoms compared to placebo. CBD dosing did not adversely impact patients’ cognitive functioning, nor was it associated with any other significant side effects."
.
Science has demonstrated that continual use of marijuana does harm to the human brain.
 
Werbung:
Back
Top